ORMP – oramed pharmaceuticals inc. (US:NASDAQ)
Stock Stats
News
11/11
11:15 pm
ormp
Low
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
11/11
11:15 pm
ormp
Low
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
10/22
02:02 am
ormp
Low
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
10/14
11:09 pm
ormp
Low
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
10/7
10:00 am
ormp
Low
Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt
8/14/2024
04:05 pm
ormp
4.9%
BEAT
5/9/2024
04:00 pm
ormp
0.6%
BEAT
9/9
08:08 am
Reiterates
Neutral
HC Wainwright
Medium
3.4%
11/8
04:34 pm
ormp
Low
Form 4 ORAMED PHARMACEUTICALS For: Nov 07 Filed by: Hexter Joshua
11/8
04:32 pm
ormp
Low
Form 4 ORAMED PHARMACEUTICALS For: Nov 07 Filed by: KIDRON NADAV
11/8
04:31 pm
ormp
Low
Form 4 ORAMED PHARMACEUTICALS For: Nov 07 Filed by: Gabay Avraham
11/8
04:31 pm
ormp
Low
Form 4 ORAMED PHARMACEUTICALS For: Nov 07 Filed by: Kidron Miriam
11/7
04:06 pm
ormp
Low
Form 10-Q ORAMED PHARMACEUTICALS For: Sep 30
Show more
Top News Gainers
11/29 Oramed Pharmaceuticals, Inc. (NASDAQ: ORMP) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 36.2%
11/27 Form 10-K ORAMED PHARMACEUTICALS For: Aug 31 17.9%
1/9 Oramed Pharmaceuticals Issues Letter to Shareholders 14.6%
11/25 Oramed working on first insulin pill for diabetes [Yahoo! Finance News] 12.5%
3/19 Oramed Receives Positive Feedback From End-of-Phase 2 Oral Insulin CMC Meeting With FDA 11.9%
11/21 Oramed Patent Granted in Japan for Protease Inhibitor, a Key Component of Platform Technology 10.3%
7/15 Form 4 ORAMED PHARMACEUTICALS For: Jul 11 Filed by: Sank Leonard 7.3%
9/20 Oramed Pharmaceuticals, Inc. (NASDAQ: ORMP) was given a new $20.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock. 6.5%
1/28 Oramed Patent in Europe to be Granted for Oral Delivery of Proteins 4.8%
9/16 Form 4 ORAMED PHARMACEUTICALS For: Sep 12 Filed by: RAKIN KEVIN 4.3%
Top News Decliners
11/12 Form 8-K ORAMED PHARMACEUTICALS For: Nov 12 -23.5%
2/26 Oramed Pharmaceuticals Inc. Announces Proposed Public Offering of Common Stock -11.4%
7/2 Oramed Announces Xiaoming Gao Joins Board of Directors -7.8%
11/19 Oramed Provides Highlights and Data From Its Phase IIb Oral Insulin Study Investor Event -7.1%
9/11 Oramed Pharmaceuticals, Inc. (NASDAQ: ORMP) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating on the stock. -5.2%
1/23 Oramed Elects Dr. Alexander Fleming to Scientific Advisory Board -4.3%
10/17 Oramed Pharmaceuticals And ORMD-0901 [Seeking Alpha] -4.2%
1/30 Oramed Appoints Dr. Julio Rosenstock to Its Scientific Advisory Board -3.9%
2/26 Oramed Reports Positive Results in the Final Cohort of Its Phase 2b Oral Insulin Trial -3.5%
5/16 Form 8-K ORAMED PHARMACEUTICALS For: May 13 -3.5%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3